Array
Over 300 biotech and pharmaceutical industry executives, including Pfizer CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge’s decision to suspend sales of the abortion pill mifepristone.
A US judge on Friday suspended the Food and Drug Administration’s two-decade-old approval of the drug, effectively banning sales while a case brought by anti-abortion groups before him continues in the Northern District of Texas.
Last week’s ruling by Judge Matthew Kacsmaryk undermines the FDA’s authority, the letter’s authors wrote, adding that it ignores decades of scientific evidence and legal precedent.
“We call for the reversal of this decision to disregard science, and the appropriate restitution of the mandate for the safety and efficacy of medicines for all with the FDA, the agency entrusted to do so in the first place,” they wrote.
